IQVIA艾昆纬：2025年中低收入国家药物获取关键路径与瓶颈报告：新上市与已上市药物数据洞察（英文版）

Access to medicines is a cornerstone of equitable healthcare and a critical determinant of health outcomes, particularly in low- and middle-income countries (LMICs), which are home to over 80% of the global population. These countries face a disproportionate burden of both communicable and non-communicable diseases, making timely access to effective treatments essential for improving population health, reducing mortality, and addressing health disparities.Ensuring the availability of both recent